Velan Capital Investment Management LP
Position in NRIX — Nurix Therapeutics, Inc.
CIK 1848809
ALPHARETTA, GA
Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$388,160
+$140,160 QoQ
Shares Held
16,000
0.0% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#140
of 210 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Velan Capital Investment Management LP holds $153,684,284 across 45 Biotechnology names. NRIX ranks #24 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
88,781 | $29,722,990 | |
| 2 | MPLT |
MapLight Therapeutics, Inc.
|
492,893 | $17,665,285 | |
| 3 | STRO |
Sutro Biopharma, Inc.
|
512,160 | $17,003,712 | |
| 4 | IMMX |
Immix Biopharma, Inc.
|
1,085,000 | $11,186,350 | |
| 5 | TARA |
Protara Therapeutics, Inc.
|
2,844,652 | $10,866,570 | |
| 6 | ABVX |
Abivax S.A.
|
65,630 | $8,745,853 | |
| 7 | TENX |
Tenax Therapeutics, Inc.
|
549,985 | $8,002,281 | |
| 8 | EDSA |
Edesa Biotech, Inc.
|
827,500 | $6,727,575 |
All Filings in NRIX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $388,160 | 16,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $248,000 | 16,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $303,520 | 16,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $147,840 | 16,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $113,900 | 10,000 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $1,844,228 | 97,889 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||